Kanagawa, Japan-based biotech startup PeptiDream Inc. has signed licensing deals with many multinational drug makers, 17 in total in 11 years, courting Roche's Genentech, Janssen Pharmaceuticals Inc. and Shionogi & Co. Ltd., among others.
The key to this track record is its proprietary Peptide Discovery Platform System (PDPS) platform, in particular, peptide-drug conjugates (PDCs),...